FENNEC PHARMACEUTICALS INC. (FENC)
Biological Products, (No Diagnostic Substances)
Latest Price
$9.57
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
1.10
P/B Ratio
8.72
Institutional Ownership
46.7% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Rosalind Advisors, Inc. | 2.91M | $17.0M | 8.42% | +294.7K | 2026-03-31 |
| Southpoint Capital Advisors LP | 2.74M | $16.0M | 7.95% | -- | 2026-03-31 |
| Solas Capital Management, LLC | 2.48M | $15.0M | 7.19% | -78.5K | 2026-03-31 |
| AIGH Capital Management LLC | 1.98M | $12.0M | 5.74% | +400.0K | 2026-03-31 |
| BlackRock, Inc. | 1.37M | $8.0M | 3.96% | +133.9K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 897.1K | $5.0M | 2.60% | -- | 2026-03-31 |
| AWM Investment Company, Inc. | 720.1K | $4.0M | 2.08% | +8.3K | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 371.7K | $2.0M | 1.08% | +74.6K | 2026-03-31 |
| STATE STREET CORP | 359.1K | $2.0M | 1.04% | +6.3K | 2026-03-31 |
| Potomac Capital Management, Inc. | 224.4K | $1.0M | 0.65% | +129.3K | 2026-03-31 |